Related Experiment Video

Updated: Aug 7, 2026

An Efficient Transgenesis Approach for Gene Delivery in the Mouse Embryonic Heart
05:06

An Efficient Transgenesis Approach for Gene Delivery in the Mouse Embryonic Heart

Published on: May 24, 2024

What makes the heart fail? New insights from defective genes

Timothy M Olson1

  • 1Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA. olson.timothy@mayo.edu

Acta Paediatrica (Oslo, Norway : 1992). Supplement
|June 28, 2006
PubMed

Insights

Dilated cardiomyopathy (DCM) is a heart muscle disease with genetic causes. Family studies show that screening relatives is crucial for early detection of this condition.

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Molecular Biology

Background:

  • Dilated cardiomyopathy (DCM) is a complex heart condition with diverse genetic origins.
  • Recent research has identified mutations in various genes affecting cardiac cell structures and function.
  • Understanding these genetic underpinnings is key to deciphering disease mechanisms.

Purpose of the Study:

  • To explore the genetic heterogeneity of dilated cardiomyopathy.
  • To elucidate the molecular pathways involved in DCM pathogenesis.
  • To establish genotype-phenotype correlations in cardiomyopathies.

Main Methods:

  • Analysis of genetic mutations in DCM patients.
  • Investigation of protein function related to cytoskeletal, sarcomeric, nuclear membrane, and sarcoplasmic reticulum.
  • Comparative studies of dilated and hypertrophic cardiomyopathies.

Main Results:

  • Identified mutations in genes critical for cardiac myocyte structural integrity and calcium handling.
  • Demonstrated that perturbations in these cellular components contribute to DCM.
  • Highlighted the relationship between DCM and hypertrophic cardiomyopathy as allelic disorders.

Conclusions:

  • Family-based studies strongly support clinical screening for first-degree relatives of DCM patients.
  • Screening is recommended irrespective of the proband's family history or age.
  • Early detection through genetic screening can aid in managing DCM and related cardiac conditions.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...